<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Premature sudden cardiovascular <z:hpo ids='HP_0011420'>death</z:hpo> is the commonest cause of <z:hpo ids='HP_0011420'>death</z:hpo> in <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e>) patients and is associated with uraemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> [<z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo> (LVH), systolic dysfunction (LVSD) or LV dilation] </plain></SENT>
<SENT sid="1" pm="."><plain>High-energy phosphates (<z:chebi fb="15" ids="48293">HEP</z:chebi>), quantified using <z:chebi fb="0" ids="37971">phosphorus-31</z:chebi> magnetic resonance spectroscopy, are reduced in patients with <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0001635'>heart failure</z:hpo> and <z:mp ids='MP_0009644'>uraemia</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Phosphocreatine:Î² <z:chebi fb="3" ids="15422">adenosine triphosphate</z:chebi> (PCr:ATP) ratio is an index of metabolic activity </plain></SENT>
<SENT sid="3" pm="."><plain>We compared resting <z:chebi fb="15" ids="48293">HEPs</z:chebi> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> patients and hypertensive patients (with and without LVH) who had <z:mpath ids='MPATH_458'>normal</z:mpath> renal function (LVH-only or <z:mpath ids='MPATH_458'>normal</z:mpath> myocardia) </plain></SENT>
<SENT sid="4" pm="."><plain>We also assessed associations of <z:chebi fb="15" ids="48293">HEP</z:chebi> levels with abnormalities of uraemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Fifty-three <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> and 30 hypertensive patients (18 with LVH, 12 with <z:mpath ids='MPATH_458'>normal</z:mpath> myocardia) underwent <z:chebi fb="81" ids="28659,35895">phosphorus</z:chebi> magnetic resonance spectroscopy of their left ventricle </plain></SENT>
<SENT sid="6" pm="."><plain>PCr:ATP ratios were calculated from (31)P-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> spectra obtained from long-axis views of the left ventricle </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: There were no significant differences in age, LV mass, chamber sizes and ejection fraction between patient groups </plain></SENT>
<SENT sid="8" pm="."><plain>PCr:ATP was significantly lower in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> patients compared to hypertensive patients, irrespective of the presence or absence of LVH (P = 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>In the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> group, PCr:ATP was significantly lower in patients with LVSD (P = 0.05) and LV dilation (P = 0.01) </plain></SENT>
<SENT sid="10" pm="."><plain>LVH was not associated with significant difference in PCr:ATP </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> patients have lower <z:chebi fb="15" ids="48293">HEP</z:chebi> levels compared to hypertensive patients </plain></SENT>
<SENT sid="12" pm="."><plain>Lower PCr:ATP ratio, indicating altered myocardial metabolic function in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> patients, is associated with features of uraemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
</text></document>